Question 1

What is the catalog number for SUPER-X PLEX ® Rat VEGF Flow Cytometry Assay - Group 2?

Accepted Answer

The catalog number for SUPER-X PLEX ® Rat VEGF Flow Cytometry Assay - Group 2 is RX31032.

Question 2

What sizes are available for SUPER-X PLEX ® Rat VEGF Flow Cytometry Assay - Group 2?

Accepted Answer

SUPER-X PLEX ® Rat VEGF Flow Cytometry Assay - Group 2 is available in the following size(s): 96 Tests.

Question 3

Is SUPER-X PLEX ® Rat VEGF Flow Cytometry Assay - Group 2 in stock?

Accepted Answer

SUPER-X PLEX ® Rat VEGF Flow Cytometry Assay - Group 2 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

How long will it take to receive this product if it’s custom made?

Accepted Answer

Lead times depend on the product type: custom polyclonal antibodies typically take 12-14 weeks, monoclonal antibodies 15-17 weeks, made-to-order recombinant proteins 4-8 weeks, and made-to-order recombinant antibodies 6-8 weeks. These are estimates and may shift due to production delays.

Question 5

What is the recommended dilution for this antibody?

Accepted Answer

A recommended dilution range for each validated application is provided on the datasheet, but optimal dilution should be titrated for your specific experimental system, sample type, and detection method.

Question 6

What is the recommended storage temperature after reconstitution?

Accepted Answer

Post-reconstitution storage guidance is listed on the datasheet, typically requiring aliquoting and storage at -20°C or -80°C to preserve activity.

SUPER-X PLEX ® Rat VEGF Flow Cytometry Assay - Group 2

Product Specifications

Gene ID

Target Antigen

Type

Frequently Asked Questions

Explore Other Products

P53 Tumor Suppressor Protein (N/A), CF594 conjugate, 0.1mg/mL

SOX2 (Transcription Factor) (SOX2/1791), 0.2mg/mL

Gp100 / Melanosome / PMEL17 / SILV (Melanoma Marker) (PMEL/2038), CF740 conjugate, 0.1mg/mL

Anti-Cardiac Troponin I/TNNI3 Antibody Picoband®

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF647 conjugate, 0.1mg/mL

CD21 (Mature B-Cell & Follicular Dendritic Cell Marker) (CR2/3247), CF568 conjugate, 0.1mg/mL